The prognosis for patients with malignant pleural mesothelioma is generally poor, partly due to late diagnosis and the aggressive nature of the disease. The average life expectancy after diagnosis ranges from 12 to 21 months, although some patients may live longer with early detection and advanced treatments. Clinical trials continue to explore new therapies to improve survival rates and quality of life.
